marketcaparena
Search

    CCEL

    CRYO CELL INTERNATIONAL INC

    Company overview

    Market capitalization
    $33.54M
    Employees
    72
    Latest publication
    2026-09-29
    About CRYO CELL INTERNATIONAL INC

    Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-05-31 · USDQ1 20262026-02-28 · USDQ3 20252025-08-31 · USDQ2 20252025-05-31 · USDQ1 20252025-02-28 · USDQ4 20242024-11-30 · USDQ3 20242024-08-31 · USDQ2 20242024-05-31 · USD
    Total Revenue7,776,113USD7,683,117USD7,825,432USD7,928,843USD7,968,880USD8,024,345USD8,066,715USD8,042,811USD
    Cost Of Revenue1,676,663USD1,656,488USD1,801,419USD1,856,539USD1,984,588USD1,636,688USD2,125,846USD2,024,750USD
    Gross Profit6,099,450USD6,026,629USD6,024,013USD6,072,304USD5,984,292USD6,387,657USD5,940,869USD6,018,061USD
    Research Development99,781USD65,761USD61,625USD131,711USD98,143USD304,629USD193,933USD241,085USD
    Selling General Administrative4,617,999USD5,011,847USD—4,257,857USD4,638,285USD6,010,431USD4,149,785USD4,021,357USD
    Total Operating Expenses4,902,109USD5,261,495USD4,123,477USD4,579,670USD4,928,281USD6,510,004USD4,550,979USD4,626,543USD
    Operating Income1,197,341USD765,134USD1,900,536USD1,492,634USD1,056,011USD-122,347USD1,389,890USD1,391,518USD
    Total Other Income Expense Net-369,560USD-694,825USD-714,540USD-917,531USD-522,293USD-720,087USD-10,025USD80,662USD
    Interest Expense441,917USD462,709USD538,219USD551,126USD494,962USD745,488USD533,464USD329,273USD
    Depreciation And Amortization184,329USD341,999USD185,693USD498,141USD339,996USD339,448USD332,472USD188,495USD
    Income Before Tax827,781USD70,309USD1,185,996USD575,103USD533,718USD-842,434USD1,379,865USD1,472,180USD
    Income Tax Expense273,195USD23,201USD-436,588USD219,318USD250,863USD1,019,181USD328,186USD816,390USD
    Net Income554,586USD47,108USD1,622,584USD355,785USD282,855USD-1,861,615USD1,051,679USD655,790USD
    Net Interest Income—-462,709USD—-551,126USD-494,962USD-745,488USD-533,464USD-329,273USD
    Tax Provision—23,201USD—219,318USD250,863USD1,019,181USD328,186USD816,390USD
    Net Income From Continuing Ops—47,108USD—355,785USD282,855USD-1,861,615USD1,051,679USD655,790USD
    Ebit—533,018USD1,724,215USD1,126,229USD1,028,680USD-96,946USD-1,816,039USD1,801,453USD
    Ebitda—875,017USD1,909,908USD1,624,370USD1,368,676USD242,502USD-1,483,567USD1,989,948USD
    Reconciled Depreciation—341,999USD—344,259USD339,996USD339,448USD332,472USD188,495USD
    Unclassified Operating Expenses——4,061,852USD—————
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-11-30 · USDFY 20242024-11-30 · USDFY 20222022-11-30 · USDFY 20212021-11-30 · USDFY 20202020-11-30 · USDFY 20192019-11-30 · USDFY 20182018-11-30 · USDFY 20172017-11-30 · USD
    Total Revenue31,566,321USD31,986,106USD30,336,749USD28,884,902USD31,147,593USD31,816,571USD29,218,490USD25,384,279USD
    Cost Of Revenue7,376,648USD7,947,752USD8,792,358USD8,989,736USD9,657,442USD10,036,175USD8,539,662USD6,724,391USD
    Gross Profit24,189,673USD24,038,354USD21,544,391USD19,895,166USD21,490,151USD21,780,396USD20,678,828USD18,659,888USD
    Research Development376,263USD1,242,536USD384,789USD49,870USD23,851USD30,145USD91,845USD41,165USD
    Selling General Administrative18,220,708USD18,521,218USD15,580,274USD14,625,311USD14,294,233USD14,891,462USD15,632,696USD13,480,883USD
    Total Operating Expenses19,348,445USD20,558,070USD17,519,924USD15,876,933USD13,828,554USD16,717,690USD15,489,525USD13,653,662USD
    Operating Income4,841,228USD3,480,284USD4,024,467USD4,018,233USD7,661,597USD5,062,706USD5,189,303USD5,006,226USD
    Interest Expense2,066,256USD1,864,684USD1,521,767USD1,378,926USD1,544,017USD1,703,446USD1,546,900USD1,302,650USD
    Net Interest Income-2,066,256USD-1,864,684USD-1,521,767USD-1,378,926USD-1,544,017USD-1,703,446USD-1,546,900USD-1,302,650USD
    Income Before Tax-2,337,153USD2,804,121USD3,318,948USD2,611,231USD5,039,323USD3,391,415USD3,617,680USD3,623,703USD
    Income Tax Expense92,232USD2,402,026USD547,540USD527,710USD1,414,727USD1,100,641USD4,472,504USD1,308,603USD
    Tax Provision92,232USD2,402,026USD547,540USD527,710USD1,414,727USD1,100,641USD4,472,504USD1,308,603USD
    Net Income-2,429,385USD402,095USD2,771,408USD2,083,521USD3,624,596USD2,290,774USD-854,824USD2,315,100USD
    Net Income From Continuing Ops-2,429,385USD402,095USD2,771,408USD2,083,521USD3,624,596USD2,290,774USD-854,824USD2,315,100USD
    Ebit-270,897USD939,437USD4,840,715USD3,990,157USD6,583,340USD5,094,861USD5,164,580USD4,926,353USD
    Ebitda1,097,221USD1,422,959USD6,650,057USD5,316,549USD7,219,315USD5,496,172USD5,481,906USD5,156,348USD
    Depreciation And Amortization1,368,118USD483,522USD1,809,342USD1,326,392USD635,975USD401,311USD317,326USD229,995USD
    Reconciled Depreciation1,368,118USD1,021,597USD1,809,342USD1,326,392USD635,975USD401,311USD317,326USD229,995USD
    Total Other Income Expense Net-7,178,381USD-676,163USD-705,519USD-1,407,000USD-2,622,274USD-1,671,291USD-1,571,623USD-1,382,523USD
    Unclassified Operating Expenses——1,554,861USD1,201,752USD—1,796,083USD——
    Net Income Applicable To Common Shares——2,771,408USD2,083,521USD3,624,596USD2,290,774USD-854,824USD2,315,100USD
    Non Operating Income Net Other————-1,078,257USD32,155USD-24,723USD-79,873USD
    Minority Interest——————0USD0USD
    Discontinued Operations——————0USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-05-31 · USDQ1 20262026-02-28 · USDQ4 20252025-11-30 · USDQ3 20252025-08-31 · USDQ2 20252025-05-31 · USDQ1 20252025-02-28 · USDQ4 20242024-11-30 · USDQ3 20242024-08-31 · USD
    Total Assets60,706,430USD60,884,986USD61,728,514USD63,169,129USD64,437,909USD64,381,067USD64,677,633USD62,934,473USD
    Cash And Equivalents507,302USD———————
    Cash And Short Term Investments3,161,967USD2,900,058USD3,296,044USD3,221,445USD4,431,004USD3,479,423USD3,496,143USD2,126,895USD
    Short Term Investments2,654,665USD2,650,386USD2,977,013USD2,956,238USD4,293,513USD3,256,301USD2,935,183USD1,929,458USD
    Total Current Assets11,304,354USD11,076,980USD11,758,221USD11,673,003USD13,052,920USD12,509,061USD12,554,593USD10,660,884USD
    Other Current Assets414,391USD1,004,239USD1,207,203USD962,924USD1,013,678USD1,087,186USD1,091,653USD928,988USD
    Other Non Current Assets28,733,474USD———————
    Total Liabilities78,463,962USD———————
    Total Current Liabilities15,929,889USD17,763,567USD19,792,987USD18,451,606USD21,752,599USD21,721,875USD21,599,542USD17,422,573USD
    Other Current Liabilities2,967,214USD———————
    Other Non Current Liabilities62,534,073USD———————
    Total Stockholder Equity-17,757,532USD-18,400,272USD-18,605,929USD-14,831,399USD-15,559,805USD-14,656,309USD-13,216,017USD-9,558,956USD
    Total Equity Including Noncontrolling Interest-17,757,532USD———————
    Deferred Revenue9,498,548USD———————
    Deferred Revenue Non Current53,269,359USD———————
    Net Receivables6,910,079USD6,815,692USD6,846,180USD6,833,380USD6,931,474USD7,211,985USD7,309,094USD6,873,641USD
    Inventory310,170USD356,991USD408,794USD655,254USD676,764USD730,467USD657,703USD731,360USD
    Property Plant Equipment Net21,290,545USD21,590,218USD21,853,998USD22,105,850USD22,012,070USD22,439,626USD22,700,602USD23,014,735USD
    Goodwill1,941,411USD———————
    Intangible Assets840,765USD851,920USD863,074USD874,229USD887,321USD904,287USD921,254USD938,221USD
    Accounts Payable2,847,104USD3,301,508USD2,870,771USD2,611,921USD2,241,446USD2,744,469USD1,882,274USD2,000,551USD
    Short Term Debt421,888USD2,026,254USD2,913,871USD3,634,604USD7,262,834USD5,200,800USD4,118,822USD2,781,206USD
    Common Stock148,846USD148,771USD148,771USD148,771USD148,696USD148,696USD148,696USD148,496USD
    Retained Earnings-37,836,544USD-38,391,130USD-38,438,238USD-34,620,805USD-35,370,213USD-34,515,310USD-32,777,626USD-28,895,472USD
    Total Liab—79,285,258USD80,334,443USD78,000,528USD79,997,714USD79,037,376USD77,893,650USD72,493,429USD
    Other Current Liab—3,078,445USD4,278,027USD2,463,762USD2,673,698USD4,336,820USD4,389,088USD2,813,906USD
    Capital Stock—148,771USD148,771USD—148,696USD148,696USD148,696USD148,496USD
    Good Will—1,941,411USD1,941,411USD1,941,411USD1,941,411USD1,941,411USD1,941,411USD1,941,411USD
    Cash—249,672USD319,031USD265,207USD137,491USD223,122USD560,960USD197,437USD
    Current Deferred Revenue—9,357,360USD9,730,318USD9,741,319USD9,574,621USD9,439,786USD9,788,574USD9,826,910USD
    Net Debt—2,145,523USD11,239,598USD3,946,599USD15,629,462USD13,637,602USD12,372,960USD11,533,431USD
    Short Long Term Debt—1,791,085USD2,483,650USD—6,797,603USD4,748,786USD3,690,488USD2,397,315USD
    Short Long Term Debt Total—2,395,195USD11,558,629USD4,211,806USD15,766,953USD13,860,724USD12,933,920USD11,730,868USD
    Long Term Debt—8,127,541USD8,170,130USD—8,238,979USD8,273,115USD8,310,045USD8,330,630USD
    Property Plant Equipment Gross—21,590,218USD28,418,506USD—22,012,070USD22,439,626USD28,343,251USD23,014,735USD
    Common Stock Shares Outstanding—8,056,133shares8,068,777shares8,073,654shares8,125,720shares8,200,022shares8,212,510shares8,173,535shares
    Non Current Assets Total—49,808,006USD49,970,293USD51,496,126USD51,384,989USD51,872,006USD52,123,040USD52,273,589USD
    Non Current Liabilities Total—61,521,691USD60,541,456USD59,548,922USD58,245,115USD57,315,501USD56,294,108USD55,070,856USD
    Non Current Liabilities Other—922,020USD922,020USD—922,020USD922,020USD922,020USD923,055USD
    Non Currrent Assets Other—1,803,746USD1,691,099USD5,772,613USD5,742,164USD5,784,659USD5,757,750USD5,886,473USD
    Net Working Capital—-6,686,587USD-8,034,766USD—-8,699,679USD-9,212,814USD-9,044,949USD-6,761,689USD
    Unclassified Non Current Assets—23,620,711USD23,620,711USD20,802,023USD20,802,023USD20,802,023USD20,802,023USD20,492,749USD
    Unclassified Current Liabilities—-1,791,085USD-2,483,650USD—-6,797,603USD-4,748,786USD-2,269,704USD-2,397,315USD
    Unclassified Non Current Liabilities—52,472,130USD51,449,306USD59,548,922USD49,084,116USD48,120,366USD47,062,043USD45,817,171USD
    Unclassified Equity—19,693,316USD19,534,767USD19,640,635USD19,513,016USD19,561,609USD19,264,217USD19,039,524USD
    Long Term Investments——————0USD0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-11-30 · USDFY 20242024-11-30 · USDFY 20232023-11-30 · USDFY 20222022-11-30 · USDFY 20212021-11-30 · USDFY 20202020-11-30 · USDFY 20192019-11-30 · USDFY 20182018-11-30 · USD
    Total Assets61,728,514USD64,677,633USD61,220,770USD64,888,054USD60,662,076USD46,200,094USD42,886,160USD42,390,143USD
    Intangible Assets863,074USD921,254USD989,121USD15,154,340USD16,211,495USD1,531,588USD1,249,254USD1,341,336USD
    Other Current Assets1,207,203USD1,091,653USD1,127,470USD993,436USD1,269,621USD856,323USD760,657USD716,280USD
    Total Liab80,334,443USD77,893,650USD72,252,002USD66,412,356USD56,477,762USD48,865,229USD49,839,011USD51,298,441USD
    Total Stockholder Equity-18,605,929USD-13,216,017USD-11,031,232USD-1,524,302USD4,184,314USD-2,665,135USD-6,952,851USD-8,908,298USD
    Other Current Liab4,278,027USD4,389,088USD4,944,332USD5,226,740USD8,014,977USD1,938,307USD1,909,134USD5,478,996USD
    Common Stock148,771USD148,696USD148,492USD148,480USD146,658USD136,336USD135,989USD135,964USD
    Capital Stock148,771USD148,696USD148,492USD148,480USD146,658USD136,336USD135,989USD135,964USD
    Retained Earnings-38,438,238USD-32,777,626USD-31,159,182USD-21,637,513USD-16,736,193USD-18,819,714USD-22,444,310USD-25,329,515USD
    Good Will1,941,411USD1,941,411USD1,941,411USD1,941,411USD1,941,411USD1,941,411USD1,941,411USD1,941,411USD
    Cash319,031USD560,960USD406,067USD1,703,958USD8,263,088USD10,361,125USD6,541,037USD6,040,033USD
    Cash And Short Term Investments3,296,044USD3,496,143USD980,250USD1,721,578USD8,338,500USD10,449,601USD7,445,090USD6,915,722USD
    Total Current Assets11,758,221USD12,554,593USD9,452,837USD9,610,185USD15,782,507USD18,556,202USD15,387,611USD29,535,210USD
    Total Current Liabilities19,792,987USD21,599,542USD20,864,000USD19,481,420USD21,073,579USD16,414,621USD15,429,429USD15,429,725USD
    Current Deferred Revenue9,730,318USD9,788,574USD9,704,553USD9,586,327USD9,358,696USD9,183,450USD8,875,138USD8,365,284USD
    Net Debt11,239,598USD12,372,960USD10,489,963USD9,910,161USD-5,441,967USD-4,120,709USD2,415,115USD6,903,477USD
    Short Term Debt2,913,871USD4,118,822USD1,614,055USD2,720,946USD2,210,132USD3,375,570USD3,100,000USD3,100,000USD
    Short Long Term Debt2,483,650USD3,690,488USD1,388,369USD2,423,255USD1,898,065USD3,100,000USD3,100,000USD3,100,000USD
    Short Long Term Debt Total11,558,629USD12,933,920USD10,896,030USD11,614,119USD2,821,121USD6,240,416USD8,956,152USD12,943,510USD
    Long Term Debt8,170,130USD8,310,045USD8,430,037USD8,579,875USD—2,841,214USD5,856,152USD9,843,510USD
    Short Term Investments2,977,013USD2,935,183USD574,183USD17,620USD75,412USD88,476USD904,053USD875,689USD
    Net Receivables6,846,180USD7,309,094USD6,576,240USD6,043,941USD5,253,173USD6,322,960USD6,097,331USD5,867,335USD
    Inventory408,794USD657,703USD768,877USD851,230USD921,213USD927,318USD1,084,533USD16,035,873USD
    Accounts Payable2,870,771USD1,882,274USD3,174,584USD1,605,301USD1,489,774USD957,390USD1,369,111USD1,261,653USD
    Property Plant Equipment Net21,853,998USD22,700,602USD22,030,040USD14,209,149USD4,146,697USD1,939,863USD1,846,467USD1,493,401USD
    Property Plant Equipment Gross28,418,506USD28,343,251USD30,163,148USD22,016,708USD11,668,857USD1,939,863USD1,846,467USD1,493,401USD
    Common Stock Shares Outstanding8,068,777shares8,212,510shares8,340,839shares8,483,994shares8,361,720shares8,140,180shares8,412,414shares7,463,051shares
    Non Current Assets Total49,970,293USD52,123,040USD51,767,933USD55,277,869USD44,879,569USD27,643,892USD27,498,549USD12,854,933USD
    Non Current Liabilities Total60,541,456USD56,294,108USD51,388,000USD46,930,936USD35,404,183USD32,450,608USD34,409,582USD35,868,716USD
    Non Current Liabilities Other922,020USD922,020USD919,226USD2,037,704USD3,518,980USD32,450,608USD4,920,057USD5,707,975USD
    Non Currrent Assets Other1,691,099USD5,757,750USD6,314,612USD9,922,570USD10,261,833USD11,559,063USD13,073,423USD113,888USD
    Net Working Capital-8,034,766USD-9,044,949USD-11,411,164USD-9,871,235USD-5,291,072USD2,141,581USD-41,818USD14,105,485USD
    Unclassified Non Current Assets23,620,711USD20,802,023USD20,184,749USD-9,922,570USD-10,261,833USD-11,559,063USD-13,073,423USD-14,889,204USD
    Unclassified Current Liabilities-2,483,650USD-2,269,704USD—-2,081,149USD-1,898,065USD-2,140,096USD-2,923,954USD-5,876,208USD
    Unclassified Non Current Liabilities51,449,306USD47,062,043USD42,038,737USD-1,724,406USD-2,907,991USD-32,426,976USD-4,920,057USD-5,707,975USD
    Unclassified Equity19,534,767USD19,264,217USD19,830,966USD19,816,251USD20,627,191USD36,445,264USD35,782,838USD35,379,418USD
    Long Term Investments—0USD308,000USD308,000USD308,000USD308,000USD308,000USD308,000USD
    Other Liab———38,037,763USD34,793,194USD29,585,762USD28,553,430USD26,025,206USD
    Other Assets———23,664,969USD22,271,966USD21,923,030USD22,153,417USD22,546,101USD
    Net Tangible Assets———-18,620,053USD-13,968,592USD-2,665,135USD-10,143,516USD-12,191,045USD
    Treasury Stock—————-20,563,357USD-20,563,357USD-19,571,113USD
    Deferred Long Term Liab———————0USD
    Accumulated Depreciation———————0USD
    Accumulated Other Comprehensive Income———————340,984USD
    Additional Paid In Capital———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-02-28 · USDQ4 20252025-11-30 · USDQ3 20252025-08-31 · USDQ2 20252025-05-31 · USDQ1 20252025-02-28 · USDQ4 20242024-11-30 · USDQ3 20242024-08-31 · USDQ2 20242024-05-31 · USD
    Net Income47,108USD-3,817,433USD749,408USD355,785USD282,855USD-1,861,615USD1,051,679USD655,790USD
    Depreciation341,999USD330,233USD353,630USD344,259USD339,996USD339,448USD332,472USD188,495USD
    Stock Based Compensation158,549USD42,903USD36,780USD40,026USD297,392USD149,693USD145,941USD178,139USD
    Other Non Cash Items458,935USD1,835,557USD3,432,010USD527,601USD307,854USD23,379USD-155,043USD174,963USD
    Change To Account Receivables-182,853USD-101,398USD-315,517USD185,132USD-174,098USD-783,870USD-400,482USD-375,994USD
    Change To Inventory51,803USD-23,540USD21,511USD92,796USD-34,577USD219,969USD86,481USD72,872USD
    Change In Working Capital-354,764USD2,889,553USD783,576USD-560,657USD-274,034USD3,506,088USD1,062,252USD576,094USD
    Total Cash From Operating Activities651,827USD1,280,813USD2,536,716USD707,014USD954,063USD2,156,993USD2,437,301USD1,773,481USD
    Capital Expenditures-67,065USD-67,226USD-38,788USD-62,408USD-62,053USD-141,681USD-319,039USD-2,685,266USD
    Free Cash Flow584,762USD1,213,587USD2,497,928USD644,606USD892,010USD2,015,312USD2,118,262USD-911,785USD
    Investments86,169USD-222,423USD—-1,502,800USD-287,484USD-1,115,649USD-665,603USD-2,754,598USD
    Total Cashflows From Investing Activities19,104USD-289,649USD1,104,601USD-1,502,800USD-287,484USD-1,115,649USD-665,603USD-2,754,598USD
    Net Borrowings-740,290USD-937,340USD—2,009,462USD1,016,122USD1,267,318USD-2,028,058USD2,212,295USD
    Total Cash From Financing Activities-740,290USD-937,340USD-3,513,601USD710,155USD-1,004,417USD-677,821USD-2,043,456USD1,203,200USD
    Dividends Paid0USD0USD—-1,210,688USD-2,020,539USD——0USD
    Change In Cash-69,359USD53,824USD127,716USD-85,631USD-337,838USD363,523USD-271,758USD222,083USD
    Begin Period Cash Flow319,031USD265,207USD137,491USD223,122USD560,960USD197,437USD469,195USD247,112USD
    End Period Cash Flow249,672USD319,031USD265,207USD137,491USD223,122USD560,960USD197,437USD469,195USD
    Other Cashflows From Financing Activities-740,290USD-937,340USD-3,513,601USD1,920,843USD1,016,122USD-2,020,539USD1,002USD228,000USD
    Sale Purchase Of Stock—0USD-80,883USD-88,619USD0USD0USD-16,400USD-1,237,095USD
    Unclassified Operating Cash Flow——-2,818,688USD—————
    Unclassified Investing Cash Flow——1,143,389USD————3,618,600USD
    Other Cashflows From Investing Activities———115,000USD—-133,333USD-133,333USD-933,334USD
    Unclassified Financing Cash Flow———-1,920,843USD-1,016,122USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-11-30 · USDFY 20242024-11-30 · USDFY 20232023-11-30 · USDFY 20222022-11-30 · USDFY 20212021-11-30 · USDFY 20202020-11-30 · USDFY 20192019-11-30 · USDFY 20182018-11-30 · USD
    Net Income-2,429,385USD402,095USD-9,521,669USD2,771,408USD2,083,521USD3,624,596USD2,290,774USD-854,824USD
    Depreciation1,368,118USD1,021,597USD1,710,411USD1,809,342USD1,326,392USD635,975USD401,311USD317,326USD
    Stock Based Compensation417,101USD781,128USD816,639USD461,345USD301,616USD622,120USD397,770USD478,378USD
    Other Non Cash Items6,103,022USD416,998USD16,679,350USD1,012,413USD1,004,043USD1,112,122USD2,469,615USD583,802USD
    Change To Account Receivables-405,881USD-1,999,759USD-1,568,689USD-1,720,386USD532,788USD-828,594USD-997,124USD-1,347,773USD
    Change To Inventory56,190USD429,178USD360,445USD490,002USD210,277USD454,943USD-27,423USD316,650USD
    Change In Working Capital2,838,438USD3,698,366USD5,985,373USD4,250,405USD4,856,688USD3,755,763USD2,281,026USD2,430,157USD
    Total Cash From Operating Activities5,478,606USD6,010,910USD8,919,754USD8,572,647USD7,926,094USD8,466,603USD6,323,207USD5,333,330USD
    Capital Expenditures-230,475USD-3,603,708USD-7,638,968USD-17,168,459USD-6,951,171USD-449,962USD-662,295USD-646,163USD
    Free Cash Flow5,248,131USD2,407,202USD1,280,786USD-8,595,812USD974,923USD8,016,641USD5,660,912USD4,687,167USD
    Investments-859,857USD-4,876,899USD-8,144,754USD-15,279,639USD-6,951,171USD457,447USD-28,364USD-136,248USD
    Total Cashflows From Investing Activities-975,332USD-4,876,899USD-8,144,754USD-15,279,639USD-6,951,171USD357,485USD-690,659USD-11,282,411USD
    Net Borrowings-1,367,575USD2,160,890USD-1,206,355USD9,285,732USD-4,100,000USD-3,100,000USD-4,100,000USD5,539,035USD
    Total Cash From Financing Activities-4,745,203USD-979,118USD-2,072,891USD147,862USD-3,072,960USD-5,004,000USD-5,131,544USD5,709,960USD
    Dividends Paid-3,231,227USD-2,020,539USD0USD-7,672,728USD0USD——0USD
    Sale Purchase Of Stock-169,502USD-1,423,871USD-799,036USD-1,819,915USD-249,377USD41,000USD-992,244USD170,925USD
    Change In Cash-241,929USD154,893USD-1,297,891USD-6,559,130USD-2,098,037USD3,820,088USD501,004USD-239,121USD
    Begin Period Cash Flow560,960USD406,067USD1,703,958USD8,263,088USD10,361,125USD6,541,037USD6,040,033USD6,279,154USD
    End Period Cash Flow319,031USD560,960USD406,067USD1,703,958USD8,263,088USD10,361,125USD6,541,037USD6,040,033USD
    Other Cashflows From Investing Activities115,000USD-1,200,000USD-799,999USD1,870,000USD-5,117,174USD-350,000USD—-136,248USD
    Other Cashflows From Financing Activities-1,513,976USD228,000USD-67,500USD16,987,501USD1,276,417USD-1,904,000USD-39,300USD1,625USD
    Unclassified Operating Cash Flow-2,818,688USD—-6,750,350USD-1,732,266USD-1,646,166USD-1,283,973USD-1,517,289USD2,378,491USD
    Unclassified Financing Cash Flow1,537,077USD——-16,632,728USD————
    Unclassified Investing Cash Flow—4,803,708USD8,438,967USD15,298,459USD12,068,345USD——-10,363,752USD
    Change To Liabilities———5,069,003USD4,780,934USD680,410USD-491,742USD-546,576USD
    Cash And Cash Equivalents Changes—————3,820,088USD501,004USD-239,121USD
    Exchange Rate Changes———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-05-31ProductProcessing And Storage Fees7,715,446USDDisclosure
    Q2 2026Quarterly · 2026-05-31ProductProduct14,182USDDisclosure
    Q2 2026Quarterly · 2026-05-31ProductPublic Banking46,485USDDisclosure
    Q2 2026Quarterly · 2026-05-31SegmentPrepacytecb14,182USDDisclosure
    Q2 2026Quarterly · 2026-05-31SegmentPublic Cord Blood Banking46,485USDDisclosure
    Q2 2026Quarterly · 2026-05-31SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service7,715,446USDDisclosure
    Q1 2026Quarterly · 2026-02-28ProductProcessing And Storage Fees7,643,113USD0001193125-26-155057
    Q1 2026Quarterly · 2026-02-28ProductProduct38,594USD0001193125-26-155057
    Q1 2026Quarterly · 2026-02-28ProductPublic Banking1,410USD0001193125-26-155057
    Q1 2026Quarterly · 2026-02-28SegmentPrepacytecb38,594USD0001193125-26-155057
    Q1 2026Quarterly · 2026-02-28SegmentPublic Cord Blood Banking1,410USD0001193125-26-155057
    Q1 2026Quarterly · 2026-02-28SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service7,643,113USD0001193125-26-155057
    Q4 2025Quarterly · 2025-11-30ProductProcessing And Storage Fees7,824,220USDLegacy provider
    Q4 2025Quarterly · 2025-11-30ProductProduct18,319USDLegacy provider
    Q4 2025Quarterly · 2025-11-30ProductPublic Banking627USDLegacy provider
    Q4 2025Quarterly · 2025-11-30SegmentPrepacytecb18,319USDLegacy provider
    Q4 2025Quarterly · 2025-11-30SegmentPublic Cord Blood Banking627USDLegacy provider
    Q4 2025Quarterly · 2025-11-30SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service7,824,220USDLegacy provider
    FY 2025Yearly · 2025-11-30ProductProcessing And Storage Fees31,382,704USD0001193125-26-083096
    FY 2025Yearly · 2025-11-30ProductProduct54,104USD0001193125-26-083096
    FY 2025Yearly · 2025-11-30ProductPublic Banking129,513USD0001193125-26-083096
    FY 2025Yearly · 2025-11-30SegmentPrepacytecb54,104USD0001193125-26-083096
    FY 2025Yearly · 2025-11-30SegmentPublic Cord Blood Banking129,513USD0001193125-26-083096
    FY 2025Yearly · 2025-11-30SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service31,382,704USD0001193125-26-083096
    Q3 2025Quarterly · 2025-08-31ProductProcessing And Storage Fees7,820,877USD0001193125-25-240385
    Q3 2025Quarterly · 2025-08-31ProductProduct436USD0001193125-25-240385
    Q3 2025Quarterly · 2025-08-31ProductPublic Banking4,119USD0001193125-25-240385
    Q3 2025Quarterly · 2025-08-31SegmentPrepacytecb436USD0001193125-25-240385
    Q3 2025Quarterly · 2025-08-31SegmentPublic Cord Blood Banking4,119USD0001193125-25-240385
    Q3 2025Quarterly · 2025-08-31SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service7,820,877USD0001193125-25-240385
    Q2 2025Quarterly · 2025-05-31ProductProcessing And Storage Fees7,871,719USD0000950170-25-095916
    Q2 2025Quarterly · 2025-05-31ProductProduct14,436USD0000950170-25-095916
    Q2 2025Quarterly · 2025-05-31ProductPublic Banking42,688USD0000950170-25-095916
    Q2 2025Quarterly · 2025-05-31SegmentPrepacytecb14,436USD0000950170-25-095916
    Q2 2025Quarterly · 2025-05-31SegmentPublic Cord Blood Banking42,688USD0000950170-25-095916
    Q2 2025Quarterly · 2025-05-31SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service7,871,719USD0000950170-25-095916
    Q1 2025Quarterly · 2025-02-28ProductProcessing And Storage Fees7,865,888USD0001193125-26-155057
    Q1 2025Quarterly · 2025-02-28ProductProduct20,913USD0001193125-26-155057
    Q1 2025Quarterly · 2025-02-28ProductPublic Banking82,079USD0001193125-26-155057
    Q1 2025Quarterly · 2025-02-28SegmentPrepacytecb20,913USD0001193125-26-155057
    Q1 2025Quarterly · 2025-02-28SegmentPublic Cord Blood Banking82,079USD0001193125-26-155057
    Q1 2025Quarterly · 2025-02-28SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service7,865,888USD0001193125-26-155057
    Q4 2024Quarterly · 2024-11-30ProductProcessing And Storage Fees7,835,058USDLegacy provider
    Q4 2024Quarterly · 2024-11-30ProductProduct28,414USDLegacy provider
    Q4 2024Quarterly · 2024-11-30ProductPublic Banking160,873USDLegacy provider
    Q4 2024Quarterly · 2024-11-30SegmentPrepacytecb28,414USDLegacy provider
    Q4 2024Quarterly · 2024-11-30SegmentPublic Cord Blood Banking160,873USDLegacy provider
    Q4 2024Quarterly · 2024-11-30SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service7,835,058USDLegacy provider
    FY 2024Yearly · 2024-11-30ProductProcessing And Storage Fees31,551,550USD0001193125-26-083096
    FY 2024Yearly · 2024-11-30ProductProduct67,884USD0001193125-26-083096
    FY 2024Yearly · 2024-11-30ProductPublic Banking366,672USD0001193125-26-083096
    FY 2024Yearly · 2024-11-30SegmentPrepacytecb67,884USD0001193125-26-083096
    FY 2024Yearly · 2024-11-30SegmentPublic Cord Blood Banking366,672USD0001193125-26-083096
    FY 2024Yearly · 2024-11-30SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service31,551,550USD0001193125-26-083096
    Q3 2024Quarterly · 2024-08-31ProductProcessing And Storage Fees7,945,470USD0001193125-25-240385
    Q3 2024Quarterly · 2024-08-31ProductProduct636USD0001193125-25-240385
    Q3 2024Quarterly · 2024-08-31ProductPublic Banking120,609USD0001193125-25-240385
    Q3 2024Quarterly · 2024-08-31SegmentPrepacytecb636USD0001193125-25-240385
    Q3 2024Quarterly · 2024-08-31SegmentPublic Cord Blood Banking120,609USD0001193125-25-240385
    Q3 2024Quarterly · 2024-08-31SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service7,945,470USD0001193125-25-240385
    FY 2023Yearly · 2023-11-30ProductProcessing And Storage Fees30,796,091USD0000950170-25-030138
    FY 2023Yearly · 2023-11-30ProductProduct66,456USD0000950170-25-030138
    FY 2023Yearly · 2023-11-30ProductPublic Banking481,148USD0000950170-25-030138
    FY 2023Yearly · 2023-11-30SegmentPrepacytecb66,456USD0000950170-25-030138
    FY 2023Yearly · 2023-11-30SegmentPublic Cord Blood Banking481,148USD0000950170-25-030138
    FY 2023Yearly · 2023-11-30SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service30,796,091USD0000950170-25-030138
    FY 2022Yearly · 2022-11-30ProductProcessing And Storage Fees29,771,123USD0000950170-24-022275
    FY 2022Yearly · 2022-11-30ProductProduct104,000USD0000950170-24-022275
    FY 2022Yearly · 2022-11-30ProductPublic Banking461,626USD0000950170-24-022275
    FY 2022Yearly · 2022-11-30SegmentPrepacytecb104,000USD0000950170-24-022275
    FY 2022Yearly · 2022-11-30SegmentPublic Cord Blood Banking461,626USD0000950170-24-022275
    FY 2022Yearly · 2022-11-30SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service29,771,123USD0000950170-24-022275
    FY 2021Yearly · 2021-11-30ProductProcessing And Storage Fees28,397,401USD0000950170-22-001637
    FY 2021Yearly · 2021-11-30ProductProcessing And Storage Royalties0USD0000950170-22-001637
    FY 2021Yearly · 2021-11-30ProductProduct111,400USD0000950170-22-001637
    FY 2021Yearly · 2021-11-30ProductPublic Banking376,101USD0000950170-22-001637
    FY 2021Yearly · 2021-11-30SegmentPrepacytecb111,400USD0000950170-23-005220
    FY 2021Yearly · 2021-11-30SegmentPublic Cord Blood Banking376,101USD0000950170-23-005220
    FY 2021Yearly · 2021-11-30SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service28,397,401USD0000950170-23-005220
    FY 2020Yearly · 2020-11-30SegmentPrepacytecb244,187USD0000950170-22-001637
    FY 2020Yearly · 2020-11-30SegmentPublic Cord Blood Banking726,554USD0000950170-22-001637
    FY 2020Yearly · 2020-11-30SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service30,176,852USD0000950170-22-001637
    FY 2019Yearly · 2019-11-30SegmentPrepacytecb172,395USD0001564590-21-009945
    FY 2019Yearly · 2019-11-30SegmentPublic Cord Blood Banking652,204USD0001564590-21-009945
    FY 2019Yearly · 2019-11-30SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service30,991,972USD0001564590-21-009945
    FY 2018Yearly · 2018-11-30SegmentPrepacytecb104,323USD0001193125-20-056695
    FY 2018Yearly · 2018-11-30SegmentPublic Cord Blood Banking296,295USD0001193125-20-056695
    FY 2018Yearly · 2018-11-30SegmentUmbilical Cord Blood And Cord Tissue Stem Cell Service28,817,872USD0001193125-20-056695
    FY 2017Yearly · 2017-11-30ProductPrepacytecb442,190USD0001193125-18-064199
    FY 2017Yearly · 2017-11-30ProductUmbilical Cord Blood And Cord Tissue Stem Cell Service24,942,089USD0001193125-18-064199
    FY 2016Yearly · 2016-11-30ProductPrepacytecb350,128USD0001193125-18-064199
    FY 2016Yearly · 2016-11-30ProductUmbilical Cord Blood And Cord Tissue Stem Cell Service22,777,919USD0001193125-18-064199
    FY 2015Yearly · 2015-11-30ProductPrepacytecb471,293USD0001193125-17-062739
    FY 2015Yearly · 2015-11-30ProductUmbilical Cord Blood And Cord Tissue Stem Cell Service20,620,138USD0001193125-17-062739

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.